{"id":"W2125872628","doi":"10.1016/s1474-4422(13)70223-0","title":"High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"Baxter Healthcare Corporation; National Institutes of Health; National Institute of Neurological Disorders and Stroke; University of Michigan","keywords":"Medicine; Modified Rankin Scale; Placebo; Clinical trial; Ischaemic stroke; Internal medicine; Albumin; Randomized controlled trial; Clinical endpoint; Stroke (engine); Physical therapy; Surgery; Ischemia; Ischemic stroke","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005366504,0.000466612,0.001883249,0.0001370326,0.0001437103,0.00004002161,0.0004105539,0.0002066384,0.0006110805],"category_scores_gemma":[0.0001242612,0.0002757918,0.0004939024,0.0001076512,0.0001764293,0.0001108686,0.0001212492,0.0003520144,0.0002711356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000658351,"about_ca_system_score_gemma":0.00008749194,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001022492,"about_ca_topic_score_gemma":0.000008725327,"domain_scores_codex":[0.9972727,0.000231723,0.0007171402,0.0006249688,0.0002712848,0.0008821617],"domain_scores_gemma":[0.9973909,0.0008786455,0.0003649866,0.001089682,0.00008937741,0.00018636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8738165,0.0005781032,0.00001839628,0.00001595815,0.001959837,0.00007103589,0.0001102493,0.00001214216,0.004924696,0.0001656654,0.1163568,0.001970662],"study_design_scores_gemma":[0.9076561,0.00651418,0.000009138428,0.000006954915,0.002698142,0.00009569935,0.0000187463,0.000941447,0.002523487,0.00005561315,0.07929153,0.0001889236],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9195637,0.0001499101,0.0003694664,0.04945189,0.001555207,0.02546257,0.00007548006,0.0001771614,0.003194579],"genre_scores_gemma":[0.9075948,0.0006276908,0.0006861726,0.01876201,0.007243734,0.03554411,0.0003033477,0.0001439616,0.02909416],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03706525,"threshold_uncertainty_score":0.9999694,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05118472457038524,"score_gpt":0.3348947917082128,"score_spread":0.2837100671378276,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}